432 results on '"Nadolski, G."'
Search Results
2. Abstract No. 242 Refractory Lymphatic Ascites After Liver Transplantation: Identification of the Underlying Mechanism of Ascites Permits Successful Percutaneous Treatment
3. Abstract No. 153 Pretreatment Sarcopenia Predicts Outcomes Post TACE
4. Abstract No. 17 Diagnosis and Lymphatic Embolization in Managing Plastic Bronchitis: Risk Factors, Outcomes, and Long-Term Follow-up
5. Abstract No. 590 Restoration of TIPS Patency After TIPS Occlusion: A 23-Year Single-Center Study
6. Abstract No. 278 Transjugular Intrahepatic Portosystemic Shunt Creation Using Intravascular Ultrasound versus Fluoroscopic Guidance: A Dual-Institution Retrospective Comparative Study
7. Abstract No. 103 Changes in the Match: Results of an IR Applicant and Program Director Survey Regarding Virtual Interviews and Step 1 Pass/Fail
8. Abstract No. 141 Development and Characterization of Patient-Derived Rat Models of Hepatocellular Carcinoma for Interventional Oncology
9. Abstract No. 537 Genetically Determined Metabotype Renders β-Catenin Mutant Hepatocellular Carcinomas Susceptible to Treatment Induced Ischemia
10. Abstract No. 188 ▪ FEATURED ABSTRACT Thoracic Duct Venous Junction Lymphoplasty: Initial Experience and Outcomes
11. Abstract No. 246 High-Throughput Drug Screening of Patient-Derived Cell Lines Identifies Novel Potential Treatment Options for Hepatocellular Carcinoma
12. Abstract No. 109 Integrated IR Residency: Perspectives of Applicants and Program Directors from the 2022 Match
13. Abstract No. 279 Retrospective Review of Non-Infectious Port Complications Leading to Port Removal
14. Abstract No. 132 Transarterial Embolization with Hydrogel Embolic System Demonstrates Improved Efficacy Compared with Particle Embolic in a Translational Rat Model of Hepatocellular Carcinoma
15. Abstract No. 284 Demographic trends in female interventional radiology trainees with the advent of the integrated interventional radiology residency: a 12-month update
16. Abstract No. 291 Development of an augmented reality web-based virtual monitor for ultrasound-guided interventions
17. Abstract No. 215 Comparison of portal vein embolization outcomes performed with n-BCA versus Embospheres and coils
18. Abstract No. 40 Lymphatic imaging-based treatment algorithm for refractory chylous ascites
19. Abstract No. 41 Intranodal glue embolization reduces number of interventions and time to resolution of post-operative pelvic and groin lymphoceles compared to sclerotherapy: a retrospective single center study
20. Abstract No. 301 Effect of transarterial embolization with lactate dehydrogenase inhibitor on target and non-target hepatocellular carcinoma tumors
21. Abstract No. 530 Focused anatomy lessons using augmented reality for teaching interventional radiology procedures
22. Abstract No. 597 Rate of referral for durable therapy for refractory ascites: an unmet need
23. Abstract No. 173 Driver mutations predict response to transarterial chemoembolization in unresectable hepatocellular carcinoma
24. Abstract No. 336 Characterization of port microbiome and chemotherapy regimen: a preliminary step for tailored antibiotic therapy
25. Abstract No. 34 Parenchymal changes on chest CT following intranodal lymphangiography on a rabbit animal model
26. Abstract No. 208 Outcomes of PTFE-covered stent grafts for central venous disease in hemodialysis patients
27. Abstract No. 346 Iatrogenic renal artery injury: arteriogram findings and outcomes after embolization
28. Abstract No. 589 Development and deployment of a virtual medical information portal to inform interventional procedures
29. Abstract No. 93 Intratumoral fibrosis as a biomarker of response following transarterial embolization in a translational rat model of hepatocellular carcinoma
30. Abstract No. 37 Value of the mesenteric lymphangiography as a new diagnostic and treatment tool in the management of chylous ascites and protein-losing enteropathy
31. Abstract No. 358 Treatment of Hepatic Post-Microwave Ablation Recurrence: Is Repeat Ablation the Best Option?
32. Abstract No. 30 Intraarterial administration of a novel metabolic inhibitor enables superior therapeutic efficacy relative to intravenous administration in a translational rodent model of hepatocellular carcinoma
33. Abstract No. 143 The patient and their port microbiome: a retrospective review of port infection leading to removal with microbiologic correlation
34. Abstract No. 113 Mitigation of sarcopenia after Denver shunt placement in patients with refractory ascites due to cirrhosis
35. Abstract No. 112 Deep learning detection of bleeds on angiography
36. Abstract No. 574 Understanding the liver abscess microbiome: outcomes of percutaneous liver parenchymal abscess drainage with microbiologic correlation
37. Abstract No. 486 Augmented reality registration of three-dimensional models: a multicenter assessment using the next-generation HoloLens 2
38. Abstract No. 560 Quality of large-volume percutaneous core biopsies of hepatocellular carcinoma for research applications
39. Abstract No. 144 Retrospective review of indications leading to port removal
40. ALBI Grade vs. Child-Pugh (CP) Score For Stratification Of Survival And Liver Function Decline In Patients With Hepatocellular Carcinoma (HCC) Treated With Radiotherapy (RT)
41. Abstract No. 478 Feasibility of artificial intelligence detection and classification of inferior vena cava filters on x-ray imaging
42. Abstract No. 422 Biomarker discovery using established and primary hepatocellular carcinoma cell lines
43. 3:36 PM Abstract No. 160 Lymphatic imaging and interventions for diagnosis and treatment of neonatal chylothorax
44. 3:36 PM Abstract No. 321 Mitigation of sarcopenia after Denver shunt placement in patients with refractory ascites
45. Abstract No. 729 Thoracic duct externalization
46. Abstract No. 614 Intranodal intraoperative mesenteric lymphangiography and embolization for chylous ascites: technical and safety features
47. 3:45 PM Abstract No. 195 Leveraging transarterial chemoembolization–induced metabolic reprogramming and CRISPR-based genome editing to identify latent tumor viability with DNP-13C-NMRS in hepatocellular carcinoma
48. Abstract No. 693 CRISPR-based genome editing identifies metabolic dependencies of a biopsy-derived hepatocellular carcinoma cell line, enabling targeted therapy selection and response evaluation
49. Abstract No. 584 Comparison of clinical outcomes in pedal and intranodal lymphangiography prior to thoracic duct embolization in traumatic chylothorax
50. 3:54 PM Abstract No. 304 Hepatobiliary toxicity in nivolumab-treated hepatocellular carcinoma in the presence or absence of transarterial chemoembolization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.